Who owns the REVANCE THERAPEUTICS trademark?

The REVANCE THERAPEUTICS trademark is owned by Revance Therapeutics, Inc..

What class is the REVANCE THERAPEUTICS trademark registered in?

The REVANCE THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for REVANCE THERAPEUTICS?

The USPTO serial number for REVANCE THERAPEUTICS is 90862492.

What is the registration number for REVANCE THERAPEUTICS?

REVANCE THERAPEUTICS is registered under USPTO registration number 7811732.

REV

USPTO Trademark Record

REGISTERED

REVANCE THERAPEUTICS

SN 90862492·Reg 7811732·Filed Aug 03, 2021

Owner Revance Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

REVANCE THERAPEUTICS (Serial No. 90862492), Registration No. 7811732, is a registered US trademark filed on Aug 03, 2021 by Revance Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: May 27, 2031

Mark Intelligence

REVANCE THERAPEUTICS (Reg. #7811732) is a registered US trademark that has been protecting its owner, Revance Therapeutics, Inc., since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Aug 03, 2021

SERIAL

90862492

REG#

7811732

REGISTERED

May 27, 2025

Owner

Applicant

Revance Therapeutics, Inc.

Entity

Corporation

State

Address

UNIT 8, THE OLIVIA CENTRE, 373-375 ANTRIM ROAD, GLENGORMLEY, BT365EB

Country

Attorney

NameJennifer Waitman

Law firm

Jennifer Waitman Kilpatrick Townsend & Stockton LLP

Address

3 Times Square, New York, NY 10036, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateAug 03, 2021

Serial Number90862492

Registration No.7811732

Registration DateMay 27, 2025

Status DateMay 27, 2025

Published for OppositionDec 21, 2021

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Aug 14, 2023

First use in commerce: Aug 14, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

48 events

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 20, 2026

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 20, 2026

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 20, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Aug 04, 2025

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Aug 04, 2025

TEAS CHANGE OF OWNER ADDRESS RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Aug 04, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Aug 04, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Aug 04, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

May 27, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 27, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

May 05, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

May 05, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Apr 30, 2025

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 30, 2025

CASE ASSIGNED TO INTENT TO USE PARALEGAL

USE AMENDMENT FILED

Feb 14, 2025

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Feb 14, 2025

TEAS STATEMENT OF USE RECEIVED

SOU TEAS EXTENSION RECEIVED

Aug 13, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

Aug 13, 2024

SOU EXTENSION 5 FILED

SOU EXTENSION 5 GRANTED

Aug 13, 2024

SOU EXTENSION 5 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 13, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 15, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Feb 14, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 GRANTED

Feb 14, 2024

SOU EXTENSION 4 GRANTED

SOU EXTENSION 4 FILED

Feb 14, 2024

SOU EXTENSION 4 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 16, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Aug 14, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Aug 14, 2023

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Aug 14, 2023

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 16, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Feb 14, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Feb 14, 2023

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Feb 14, 2023

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 05, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Aug 03, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Aug 03, 2022

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Aug 03, 2022

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 15, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Dec 21, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 21, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 01, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Nov 16, 2021

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Nov 16, 2021

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Nov 16, 2021

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Nov 16, 2021

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 16, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Nov 15, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 28, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Aug 06, 2021

NEW APPLICATION ENTERED

REVANCE THERAPEUTICS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Revance Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Jennifer Waitman

Resources

Company